GoodRx reported falling revenue for the fourth quarter, but its stock rallied early Wednesday after beating earnings expectations. The company, best known for its drug cost transparency tools, reported $184.1 million in revenue for Q4…
Continue Reading
By Mark Melchionna March 01, 2023 – Published in the March Issue of Plastic and Reconstructive Surgery, new research provided evidence surrounding the demographic characteristics, such as income, race, and area of…
Continue Reading
What You Should Know:– New KeyCare survey finds nearly 7 in 10 (68%) of consumers who needed minor but urgent medical services while traveling in the prior year received care via telehealth visits with their regular physicians or affiliated members of their physicians’ care teams, outpacing…
Continue Reading
The Federal Trade Commission has cited telehealth and prescription drug discount provider GoodRx for sharing sensitive consumer health data with several advertising platforms, in violation of its own privacy promises to consumers.
The agency has filed a proposed order demanding that GoodRx pay $1.5 million in civil penalties for failing to let consumers know about unauthorized disclosures of its data to a list of advertiser platforms. including Facebook and Google.
The company, which is based in California, operates a digital health platform offering prescription drug discounts, telehealth visits and other health services. It captures a wide range of data from consumers who use…
